INDAZOLE BENZIMIDAZOLE COMPOUND AS INHIBITOR OF TYROSINE KINASE AND SERINE/THREONINE KINASE
PROBLEM TO BE SOLVED: To provide an inhibitor of tyrosine kinaze or serine/threonine kinaze. SOLUTION: The inhibitor is an organic compound represented by 3-(1H-benzimidazol-2-yl)-1H-indazole. Its pharmaceutical formulation and medicine contain an organic compound or its pharmaceutically acceptable...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MCCREA BILL MACHAJEWSKI TIM THOMAS TERESA MCBRIDE CHRIS POON DANIEL PECCI SABINA SILVER JOEL SHAFER CYNTHIA M RENHOWE PAUL A |
| description | PROBLEM TO BE SOLVED: To provide an inhibitor of tyrosine kinaze or serine/threonine kinaze. SOLUTION: The inhibitor is an organic compound represented by 3-(1H-benzimidazol-2-yl)-1H-indazole. Its pharmaceutical formulation and medicine contain an organic compound or its pharmaceutically acceptable carrier and are prepared by mixing the organic compound or its pharmaceutically acceptable salt and the carrier and water. The method for treating a patient includes a step of administering the pharmaceutical formulation and medicine to the patient who needs these. COPYRIGHT: (C)2010,JPO&INPIT |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2010018616A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2010018616A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2010018616A3</originalsourceid><addsrcrecordid>eNrjZIj29HNxjPL3cVVwcvWL8vT1hPKc_X0D_EP9XBQcgxU8_Tw8nTxD_IMU_N0UQiKD_IM9_VwVvD39HINdFRyBaoJdg4Ai-iEeQa7-fgg5HgbWtMSc4lReKM3NoOTmGuLsoZtakB-fWlyQmJyal1oS7xVgZGBoYGBoYWZo5mhMlCIACCkyqA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INDAZOLE BENZIMIDAZOLE COMPOUND AS INHIBITOR OF TYROSINE KINASE AND SERINE/THREONINE KINASE</title><source>esp@cenet</source><creator>MCCREA BILL ; MACHAJEWSKI TIM ; THOMAS TERESA ; MCBRIDE CHRIS ; POON DANIEL ; PECCI SABINA ; SILVER JOEL ; SHAFER CYNTHIA M ; RENHOWE PAUL A</creator><creatorcontrib>MCCREA BILL ; MACHAJEWSKI TIM ; THOMAS TERESA ; MCBRIDE CHRIS ; POON DANIEL ; PECCI SABINA ; SILVER JOEL ; SHAFER CYNTHIA M ; RENHOWE PAUL A</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide an inhibitor of tyrosine kinaze or serine/threonine kinaze. SOLUTION: The inhibitor is an organic compound represented by 3-(1H-benzimidazol-2-yl)-1H-indazole. Its pharmaceutical formulation and medicine contain an organic compound or its pharmaceutically acceptable carrier and are prepared by mixing the organic compound or its pharmaceutically acceptable salt and the carrier and water. The method for treating a patient includes a step of administering the pharmaceutical formulation and medicine to the patient who needs these. COPYRIGHT: (C)2010,JPO&INPIT</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100128&DB=EPODOC&CC=JP&NR=2010018616A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100128&DB=EPODOC&CC=JP&NR=2010018616A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MCCREA BILL</creatorcontrib><creatorcontrib>MACHAJEWSKI TIM</creatorcontrib><creatorcontrib>THOMAS TERESA</creatorcontrib><creatorcontrib>MCBRIDE CHRIS</creatorcontrib><creatorcontrib>POON DANIEL</creatorcontrib><creatorcontrib>PECCI SABINA</creatorcontrib><creatorcontrib>SILVER JOEL</creatorcontrib><creatorcontrib>SHAFER CYNTHIA M</creatorcontrib><creatorcontrib>RENHOWE PAUL A</creatorcontrib><title>INDAZOLE BENZIMIDAZOLE COMPOUND AS INHIBITOR OF TYROSINE KINASE AND SERINE/THREONINE KINASE</title><description>PROBLEM TO BE SOLVED: To provide an inhibitor of tyrosine kinaze or serine/threonine kinaze. SOLUTION: The inhibitor is an organic compound represented by 3-(1H-benzimidazol-2-yl)-1H-indazole. Its pharmaceutical formulation and medicine contain an organic compound or its pharmaceutically acceptable carrier and are prepared by mixing the organic compound or its pharmaceutically acceptable salt and the carrier and water. The method for treating a patient includes a step of administering the pharmaceutical formulation and medicine to the patient who needs these. COPYRIGHT: (C)2010,JPO&INPIT</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIj29HNxjPL3cVVwcvWL8vT1hPKc_X0D_EP9XBQcgxU8_Tw8nTxD_IMU_N0UQiKD_IM9_VwVvD39HINdFRyBaoJdg4Ai-iEeQa7-fgg5HgbWtMSc4lReKM3NoOTmGuLsoZtakB-fWlyQmJyal1oS7xVgZGBoYGBoYWZo5mhMlCIACCkyqA</recordid><startdate>20100128</startdate><enddate>20100128</enddate><creator>MCCREA BILL</creator><creator>MACHAJEWSKI TIM</creator><creator>THOMAS TERESA</creator><creator>MCBRIDE CHRIS</creator><creator>POON DANIEL</creator><creator>PECCI SABINA</creator><creator>SILVER JOEL</creator><creator>SHAFER CYNTHIA M</creator><creator>RENHOWE PAUL A</creator><scope>EVB</scope></search><sort><creationdate>20100128</creationdate><title>INDAZOLE BENZIMIDAZOLE COMPOUND AS INHIBITOR OF TYROSINE KINASE AND SERINE/THREONINE KINASE</title><author>MCCREA BILL ; MACHAJEWSKI TIM ; THOMAS TERESA ; MCBRIDE CHRIS ; POON DANIEL ; PECCI SABINA ; SILVER JOEL ; SHAFER CYNTHIA M ; RENHOWE PAUL A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2010018616A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MCCREA BILL</creatorcontrib><creatorcontrib>MACHAJEWSKI TIM</creatorcontrib><creatorcontrib>THOMAS TERESA</creatorcontrib><creatorcontrib>MCBRIDE CHRIS</creatorcontrib><creatorcontrib>POON DANIEL</creatorcontrib><creatorcontrib>PECCI SABINA</creatorcontrib><creatorcontrib>SILVER JOEL</creatorcontrib><creatorcontrib>SHAFER CYNTHIA M</creatorcontrib><creatorcontrib>RENHOWE PAUL A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MCCREA BILL</au><au>MACHAJEWSKI TIM</au><au>THOMAS TERESA</au><au>MCBRIDE CHRIS</au><au>POON DANIEL</au><au>PECCI SABINA</au><au>SILVER JOEL</au><au>SHAFER CYNTHIA M</au><au>RENHOWE PAUL A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INDAZOLE BENZIMIDAZOLE COMPOUND AS INHIBITOR OF TYROSINE KINASE AND SERINE/THREONINE KINASE</title><date>2010-01-28</date><risdate>2010</risdate><abstract>PROBLEM TO BE SOLVED: To provide an inhibitor of tyrosine kinaze or serine/threonine kinaze. SOLUTION: The inhibitor is an organic compound represented by 3-(1H-benzimidazol-2-yl)-1H-indazole. Its pharmaceutical formulation and medicine contain an organic compound or its pharmaceutically acceptable carrier and are prepared by mixing the organic compound or its pharmaceutically acceptable salt and the carrier and water. The method for treating a patient includes a step of administering the pharmaceutical formulation and medicine to the patient who needs these. COPYRIGHT: (C)2010,JPO&INPIT</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JP2010018616A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | INDAZOLE BENZIMIDAZOLE COMPOUND AS INHIBITOR OF TYROSINE KINASE AND SERINE/THREONINE KINASE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T12%3A33%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MCCREA%20BILL&rft.date=2010-01-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2010018616A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |